Overwhelming evidence exists to support the importance of T lymphocytes and other immunologically competent cells in the pathogenesis of psoriasis. We have used a cell-by-cell approach to examine the immunopathogenic roles of both epidermal and dermal components. The immunopharmacologic targeting of these various cellular and molecular events has provided new treatments and fresh insights into this disease.